• MAPK10-Driven Keratin 16 Degradation Suppresses NSCLC Metast

  2026-05-09

  This study uncovers a novel MAPK10/KRT16/RNF213 axis that restricts non-small cell lung cancer (NSCLC) metastasis through phosphorylation-dependent ubiquitination and degradation of keratin 16. The findings highlight MAPK10 as a prognostic biomarker and therapeutic target, opening new routes for personalized cancer therapy.

• Muscle-Derived BDNF Orchestrates Early NMJ Postsynaptic Asse

  2026-05-09

  This study uncovers how muscle-generated BDNF, via spatially localized and calcium-dependent release, regulates the initial formation of postsynaptic acetylcholine receptor (AChR) clusters at neuromuscular junctions. The findings clarify the mechanistic role of BDNF trafficking and proteolytic processing in neuromuscular synapse development, providing a foundation for targeted manipulation of synaptic assembly in muscle biology.

• 3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re

  2026-05-08

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab effectively overcomes both intrinsic and acquired cetuximab resistance in colorectal cancer cells by inducing autophagy-dependent ferroptosis and apoptosis. Mechanistically, the combination restores FOXO3a signaling and activates key cell death pathways, offering a promising strategy for resistant colorectal cancer.

• Metabolite Regulation of TET2: A Protocol for Functional Int

  2026-05-07

  Zhang et al. present a detailed protocol for elucidating how cellular metabolites bind and regulate human TET2 dioxygenase, an epigenetic enzyme. By integrating biochemical assays and saturation transfer difference (STD) NMR, the workflow enables systematic identification of activating and inhibitory metabolites, offering new precision for dissecting metabolism-epigenetics crosstalk.

• Biotin (Vitamin B7): Precision Biotinylation & Metabolic Ana

  2026-05-07

  Unlock the dual power of Biotin (Vitamin B7) for both advanced protein biotinylation and metabolic pathway interrogation. Discover lab-validated protocols, troubleshooting insights, and how recent kinesin-1 research translates to superior workflow design.

• Mubritinib-HSA Interactions: Mechanistic Insights for Drug D

  2026-05-06

  This study elucidates the binding mechanism between the mitochondrial complex I inhibitor mubritinib and human serum albumin (HSA), using multispectroscopic analysis and molecular docking. The findings reveal moderate affinity binding at Sudlow site I, resulting in functional and structural changes in HSA, which are vital for understanding pharmacokinetics and optimizing drug delivery in cancer and metabolic disease contexts.

• Sulfo-NHS-SS-Biotin: Precision in Cleavable Protein Biotinyl

  2026-05-06

  Explore the scientific principles and unique advantages of Sulfo-NHS-SS-Biotin, a biotin disulfide N-hydroxysulfosuccinimide ester for cleavable protein labeling. This article offers an advanced perspective on its utility in protein purification and membrane trafficking studies.

• Sulfo-NHS-SS-Biotin Kit: Precise, Reversible Cell Surface La

  2026-05-05

  The Sulfo-NHS-SS-Biotin Kit enables water-soluble, amine-specific, and reversible biotinylation of proteins and antibodies. Its disulfide-cleavable spacer guarantees selective cell surface labeling with medium-length linkage, supporting advanced proteomic and affinity purification workflows. Rigorously benchmarked, the reagent’s negative charge prevents membrane permeation for high-fidelity interactome mapping.

• Thiazovivin: ROCK Inhibitor Guidance for Stem Cell Workflows

  2026-05-05

  Thiazovivin addresses two major technical hurdles in stem cell research: improving the survival of human embryonic stem cells after dissociation and enhancing the efficiency of fibroblast-to-iPSC reprogramming. It is not suitable for diagnostic or clinical applications, and all procedures must adhere to research-only environments.

• BMN 673 (Talazoparib): Mechanistic Insight and Assay Strateg

  2026-05-04

  Explore the latest mechanistic advances and assay strategies for BMN 673 (Talazoparib) in DNA repair deficiency targeting. This article delivers unique, evidence-backed guidance for optimizing homologous recombination deficient cancer research.

• Sulfo-NHS-SS-Biotin Kit: Precision Cell Surface Labeling & R

  2026-05-04

  The Sulfo-NHS-SS-Biotin Kit enables reversible, water-soluble biotinylation of proteins and cell surfaces with high specificity. Its disulfide-cleavable linker and amine-reactive chemistry facilitate dynamic proteomic workflows, with proven utility in affinity purification and high-fidelity interactome mapping.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Applied Workflow

  2026-05-03

  The One-step TUNEL Cy5 Apoptosis Detection Kit delivers high-sensitivity, quantitative apoptosis detection for both tissue sections and cultured cells. This article unpacks experimental workflows, key troubleshooting strategies, and advanced use-cases—empowering researchers to decode programmed cell death mechanisms with confidence.

• TBK1 Inhibition Mitigates Painful Diabetic Neuropathy via Mi

  2026-05-02

  This study uncovers a causal role for TANK-binding kinase 1 (TBK1) in the development of painful diabetic neuropathy (PDN) by promoting microglial pyroptosis. Targeted inhibition of TBK1, either genetically or pharmacologically, effectively reduced neuropathic pain and neuroinflammation in diabetic mouse models, suggesting new therapeutic avenues for PDN.

• HyperScript™ Reverse Transcriptase: Enabling Transcriptomic

  2026-05-02

  Discover how HyperScript™ Reverse Transcriptase empowers high-fidelity cDNA synthesis for qPCR and advanced transcriptomics—especially in studies of adaptive transcriptional regulation. This article uniquely bridges enzyme technology with cellular signaling research and practical assay design.

• Lypressin Acetate in Research: Protocols and Antidiuretic In

  2026-05-01

  Lypressin acetate delivers precise vasopressor and antidiuretic performance for translational studies, streamlining experimental workflows from diabetes insipidus modeling to emerging antiviral screens. APExBIO’s high-purity formulation ensures reproducibility and robust receptor agonism, making it an indispensable tool in vasopressin analog research.

16744 records 1/1117 page Next 12345 下5页 Last page